Cancer 1995, 76 (5) : 853–9.CrossRefPubMed 16. Arai Y, Tsukuda M, Ito K, Enomoto H, Furukawa M, Kubota A, Yanoma S, Okamoto N: Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas. Auris Nasus Larynx 1997, 24 (2) : 193–8.CrossRefPubMed 17. Rubio Bueno P, Naval Gias L, Garcia Delgado R, Domingo Cebollada J, Diaz Gonzalez FJ: Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head & Neck 1998, 20 (3) : 232–39.CrossRef 18. Goldsmith MM, Cresson DH, Arnold LA, Postma DS, Askin FB, Pillsbury HC: DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck

Surg 1987, 96 (4) : 307–18.PubMed 19. Borst GR, Belderbos JS, Boellaard R, Comans EF, De Jaeger K, Lammertsma AA, Lebesque JV: Standardised FDG uptake: a prognostic factor for inoperable mTOR inhibitor non-small cell lung cancer. Eur J Cancer 2005, 41 (11) : 1533–41.CrossRefPubMed 20. Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S: 18-Fluorodeoxyglucose positron emission tomography

in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg 2003, 7 (8) : 953–9. discussion 59–60.CrossRefPubMed 21. Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M: FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 2002, 86 (4) : 512–6.CrossRefPubMed 22. Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner selleck Farnesyltransferase W, Whiteside TL: Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003, 97 (4) : 1015–24.CrossRefPubMed 23. Brun E, Kjellen

E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE: FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002, 24 (2) : 127–35.CrossRefPubMed 24. Schoder H, Yeung HW: Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 2004, 34 (3) : 180–97.CrossRefPubMed 25. Smith TA, Titley JC, McCready VR: Proliferation is associated with 2-deoxy-D-[1–3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells. Nucl Med Biol 1998, 25 (5) : 481–5.CrossRefPubMed 26. Minn H, Joensuu H, Ahonen A, Klemi P: Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988, 61 (9) : 1776–81.CrossRefPubMed 27. Smith TA, Titley J: Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction. Int J Radiat Oncol Biol Phys 2000, 47 (1) : 219–23.CrossRefPubMed 28.